Get started
Author

Danyang Wang

Androgen Signaling Contributes to Sex Differences in Cancer by Inhibiting NF-κB Activation in T Cells and Suppressing Antitumor Immunity
2023 · Xiaomin Zhang, Limin Cheng, et al. · Cancer Research · 86
PDF
NKG2D CAR-NK adoptive cellular immunotherapy combined with or without PD-1 blockade in the treatment of patients with metastatic colorectal cancer: an exploratory study
2025 · Danyang Wang, Bin Li, et al. · Cancer Immunology Immunotherapy · 23
PDF
Proximity Labeling and Genetic Screening Reveal that DSG2 is a Counter Receptor of Siglec‐9 and Suppresses Macrophage Phagocytosis
2025 · Ying Wu, Yuyu You, et al. · Advanced Science · 7
PDF
Immunotherapy Inhibits Tumor Cholesterol Synthesis via the IFNγ–IRF1–SREBF2 Axis
2025 · Liping Xu, Xiaomin Zhang, et al. · Cancer Immunology Research · 1
The significance of risk stratification through nomogram-based assessment in determining postmastectomy radiotherapy for patients diagnosed with pT1 − 2N1M0 breast cancer
2024 · Chao Wei, Jie Kong, et al. · Radiation Oncology · 1
PDF
Supplementary Table 10 from Immunotherapy Inhibits Tumor Cholesterol Synthesis via the IFNγ–IRF1–SREBF2 Axis
2026 · Liping Xu, Xiaomin Zhang, et al.
Supplementary Figure 1 from Immunotherapy Inhibits Tumor Cholesterol Synthesis via the IFNγ–IRF1–SREBF2 Axis
2026 · Liping Xu, Xiaomin Zhang, et al.
Supplementary Table 3 from Immunotherapy Inhibits Tumor Cholesterol Synthesis via the IFNγ–IRF1–SREBF2 Axis
2026 · Liping Xu, Xiaomin Zhang, et al.
Supplementary Table 6 from Immunotherapy Inhibits Tumor Cholesterol Synthesis via the IFNγ–IRF1–SREBF2 Axis
2026 · Liping Xu, Xiaomin Zhang, et al.
Supplementary Table 1 from Immunotherapy Inhibits Tumor Cholesterol Synthesis via the IFNγ–IRF1–SREBF2 Axis
2026 · Liping Xu, Xiaomin Zhang, et al.
Supplementary Table 5 from Immunotherapy Inhibits Tumor Cholesterol Synthesis via the IFNγ–IRF1–SREBF2 Axis
2026 · Liping Xu, Xiaomin Zhang, et al.
Supplementary Table 9 from Immunotherapy Inhibits Tumor Cholesterol Synthesis via the IFNγ–IRF1–SREBF2 Axis
2026 · Liping Xu, Xiaomin Zhang, et al.
Supplementary Table 7 from Immunotherapy Inhibits Tumor Cholesterol Synthesis via the IFNγ–IRF1–SREBF2 Axis
2026 · Liping Xu, Xiaomin Zhang, et al.
Supplementary Table 11 from Immunotherapy Inhibits Tumor Cholesterol Synthesis via the IFNγ–IRF1–SREBF2 Axis
2026 · Liping Xu, Xiaomin Zhang, et al.
Supplementary Table 4 from Immunotherapy Inhibits Tumor Cholesterol Synthesis via the IFNγ–IRF1–SREBF2 Axis
2026 · Liping Xu, Xiaomin Zhang, et al.
Supplementary Table 8 from Immunotherapy Inhibits Tumor Cholesterol Synthesis via the IFNγ–IRF1–SREBF2 Axis
2026 · Liping Xu, Xiaomin Zhang, et al.
Supplementary Table 2 from Immunotherapy Inhibits Tumor Cholesterol Synthesis via the IFNγ–IRF1–SREBF2 Axis
2026 · Liping Xu, Xiaomin Zhang, et al.
Supplementary Figure 2 from Immunotherapy Inhibits Tumor Cholesterol Synthesis via the IFNγ–IRF1–SREBF2 Axis
2026 · Liping Xu, Xiaomin Zhang, et al.
Data from Immunotherapy Inhibits Tumor Cholesterol Synthesis via the IFNγ–IRF1–SREBF2 Axis
2026 · Liping Xu, Xiaomin Zhang, et al.
Comparison of the efficacy between radiotherapy alone and surgery plus radiotherapy for ipsilateral supraclavicular lymph node metastasis in breast cancer based on propensity score matching analysis: a retrospective study with 8-year follow-up
2025 · Chao Wei, Shuhua Zhou, et al. · BMC Cancer
Supplementary Figure 1 from Androgen Signaling Contributes to Sex Differences in Cancer by Inhibiting NF-κB Activation in T Cells and Suppressing Antitumor Immunity
2025 · Xiaomin Zhang, Limin Cheng, et al.
PDF
Supplementary Figure Legends from Androgen Signaling Contributes to Sex Differences in Cancer by Inhibiting NF-κB Activation in T Cells and Suppressing Antitumor Immunity
2025 · Xiaomin Zhang, Limin Cheng, et al.
Supplementary Table 1 from Androgen Signaling Contributes to Sex Differences in Cancer by Inhibiting NF-κB Activation in T Cells and Suppressing Antitumor Immunity
2025 · Xiaomin Zhang, Limin Cheng, et al.
Supplementary Figure 2 from Androgen Signaling Contributes to Sex Differences in Cancer by Inhibiting NF-κB Activation in T Cells and Suppressing Antitumor Immunity
2025 · Xiaomin Zhang, Limin Cheng, et al.
Supplementary Table 2 from Androgen Signaling Contributes to Sex Differences in Cancer by Inhibiting NF-κB Activation in T Cells and Suppressing Antitumor Immunity
2025 · Xiaomin Zhang, Limin Cheng, et al.
Works count: 41
Citation count: 118
H-index: 3
I10-index: 2
Year
Topic
Type